162 related articles for article (PubMed ID: 32202704)
1. Sensitivity of cervico-vaginal cytology in endometrial carcinoma: A systematic review and meta-analysis.
Frias-Gomez J; Benavente Y; Ponce J; Brunet J; Ibáñez R; Peremiquel-Trillas P; Baixeras N; Zanca A; Piulats JM; Aytés Á; Matias-Guiu X; Bosch FX; de Sanjosé S; Alemany L; Costas L;
Cancer Cytopathol; 2020 Nov; 128(11):792-802. PubMed ID: 32202704
[TBL] [Abstract][Full Text] [Related]
2. Abnormal cervical cytology: a risk factor for endometrial cancer recurrence.
Brown AK; Gillis S; Deuel C; Angel C; Glantz C; Dubeshter B
Int J Gynecol Cancer; 2005; 15(3):517-22. PubMed ID: 15882179
[TBL] [Abstract][Full Text] [Related]
3. Contribution of cervical cytology in the diagnostic work-up of patients with endometrial cancer.
Amkreutz LCM; Pijnenborg JMA; Joosten DWL; Mertens HJMM; Van Kuijk SMJ; Engelen MJA; Bergmans M; Nolting WE; Kruitwagen RFPM
Cytopathology; 2018 Feb; 29(1):63-70. PubMed ID: 29280216
[TBL] [Abstract][Full Text] [Related]
4. Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance.
Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H; Yamasaki F
Gynecol Oncol; 1999 Mar; 72(3):273-7. PubMed ID: 10053095
[TBL] [Abstract][Full Text] [Related]
5. The Value of Papanicolaou Tests in the Diagnosis of Endometrial Carcinoma: A Large Study Cohort From an Academic Medical Center.
Serdy K; Yildiz-Aktas I; Li Z; Zhao C
Am J Clin Pathol; 2016 Mar; 145(3):350-4. PubMed ID: 27124917
[TBL] [Abstract][Full Text] [Related]
6. Pap smears in women with endometrial carcinoma.
Gu M; Shi W; Barakat RR; Thaler HT; Saigo PE
Acta Cytol; 2001; 45(4):555-60. PubMed ID: 11480718
[TBL] [Abstract][Full Text] [Related]
7. Cervical cytology in menopausal women at high risk for endometrial disease.
Van den Bosch T; Vandendael A; Wranz PA; Lombard CJ
Eur J Cancer Prev; 1998 Apr; 7(2):149-52. PubMed ID: 9818777
[TBL] [Abstract][Full Text] [Related]
8. The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma.
Ayhan A; Bozdag G; Taskiran C; Gultekin M; Yuce K; Kucukali T
Gynecol Oncol; 2006 Dec; 103(3):902-5. PubMed ID: 16828847
[TBL] [Abstract][Full Text] [Related]
9. Vaginal brachytherapy alone for patients with Stage II endometrial cancer with inner half cervical stromal invasion.
Barnes EA; Parra-Herran C; Martell K; Barbera L; Taggar A; Leung E
Brachytherapy; 2019; 18(5):606-611. PubMed ID: 31200993
[TBL] [Abstract][Full Text] [Related]
10. The utility and management of vaginal cytology after treatment for endometrial cancer.
Novetsky AP; Kuroki LM; Massad LS; Hagemann AR; Thaker PH; Powell MA; Mutch DG; Zighelboim I
Obstet Gynecol; 2013 Jan; 121(1):129-35. PubMed ID: 23262937
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of cervico-vaginal cytology in endometrial cancer.
Demirkiran F; Arvas M; Erkun E; Kosebay D; Isiloglu H; Aktas E; Mil Z
Eur J Gynaecol Oncol; 1995; 16(5):403-9. PubMed ID: 8549608
[TBL] [Abstract][Full Text] [Related]
12. [Clinical implications of positive peritoneal cytology in endometrial cancer].
Ren YL; Wang HY; Shan BE; Ping B; Shi DR
Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518
[TBL] [Abstract][Full Text] [Related]
13. Abnormal cervical cytology in the diagnosis of uterine papillary serous carcinoma: earlier detection of a poor prognostic cancer subtype?
Skaznik-Wikiel ME; Ueda SM; Frasure HE; Rose PG; Fleury A; Grumbine FC; Fader AN
Acta Cytol; 2011; 55(3):255-60. PubMed ID: 21525737
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of cervical cytology in endometrial cancer detection in a tertiary hospital in Spain.
Frias-Gomez J; Tovar E; Vidal A; Murgui L; Ibáñez R; Peremiquel-Trillas P; Paytubi S; Baixeras N; Zanca A; Ponce J; Pineda M; Brunet J; de Sanjosé S; Bosch FX; Matias-Guiu X; Alemany L; Costas L;
Cancer Med; 2021 Oct; 10(19):6762-6766. PubMed ID: 34480514
[TBL] [Abstract][Full Text] [Related]
15. Cervical cytology in serous and endometrioid endometrial cancer.
Roelofsen T; Geels YP; Pijnenborg JM; van Ham MA; Zomer SF; van Tilburg JM; Snijders MP; Siebers AG; Bulten J; Massuger LF
Int J Gynecol Pathol; 2013 Jul; 32(4):390-8. PubMed ID: 23722512
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic characteristics of recurrent endometrioid endometrial cancer patients and analysis of methods used durıing surveillance.
Simsek SY; Serbetcioglu G; Alemdaroglu S; Yetkinel S; Durdag GD; Celik H
J Gynecol Obstet Hum Reprod; 2019 Sep; 48(7):473-477. PubMed ID: 31212025
[TBL] [Abstract][Full Text] [Related]
17. Does Cytological Laboratory Holds the Responsibility for the Low Sensitivity of the PAP Test in Detecting Endometrial Cancer?
Milicić V; Matić TS; Martinek V; Tomasković I; Ramljak V
Coll Antropol; 2015 Sep; 39(3):713-7. PubMed ID: 26898071
[TBL] [Abstract][Full Text] [Related]
18. Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli M; Turan V; Gungorduk K; Hasdemir P; Tosun G; Dogan A; Ozdemir A; Adiyeke M; Sanci M
Aust N Z J Obstet Gynaecol; 2015 Feb; 55(1):81-6. PubMed ID: 25688821
[TBL] [Abstract][Full Text] [Related]
19. Cervicovaginal cytology in uterine adenocarcinoma and adenosquamous carcinoma. Comparison of cytologic and histologic findings.
Costa MJ; Kenny MB; Naib ZM
Acta Cytol; 1991; 35(1):127-34. PubMed ID: 1994621
[TBL] [Abstract][Full Text] [Related]
20. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
